Abstract
PGCS-NPs (40 nm) with excellent photothermal activity are developed, on the surface of which affibody peptides with specific affinity for EGFR and many small gold dots (1-3 nm) are densely presented. The IV-injected PGCS-NPs into EGFR-expressing tumor-bearing mice successfully perform targeted and photothermal therapy of cancer. It seems that the small gold dots released from disassembled PGCS-NPs are easily removed and never cause in vivo toxicity problems.
| Original language | English |
|---|---|
| Pages (from-to) | 6436-6441 |
| Number of pages | 6 |
| Journal | Advanced Materials |
| Volume | 26 |
| Issue number | 37 |
| DOIs | |
| State | Published - 1 Oct 2014 |
Bibliographical note
Publisher Copyright:© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- core/shell
- gold nanoparticle
- nanotoxicity
- photothermal therapy
- proteinticle
Fingerprint
Dive into the research topics of 'Proteinticle/Gold Core/Shell Nanoparticles for Targeted Cancer Therapy without Nanotoxicity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver